IMDS nasdaq bulletin board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan O who wrote (3094)	4/3/1999 2:03:00 PM
From: Andrew Abraham	Read Replies (1) of 4122

Dan O posted: Please compare the following two quotes - the first from Dick denying that he and his company ever improperly promoted the Lintroscan and the second from the FDA auditor saying that they did: Grable: "The FDA action taken in Wisconsin concerning the LINTRO-SCAN resulted because of the irresponsible action of the individual who owned the LINTRO-SCAN and personally chose to promote it improperly. The individual promoted the LINTRO-SCAN as a REPLACEMENT FOR MAMMOGRAPHY, A CLAIM NEVER MADE BY ME OR ANYONE DIRECTLY ASSOCIATED WITH THE COMPANY. Mrs. Grable nor I had any control over the device nor how it was promoted or used after it was sold. The posting presents this fact in a totally different manner." Richard Grable email previously posted on this board (capital emphasis mine). Also compare Richard Grable's statement with this section of FDA investigator Leon Law's report: (http://www.aaskolnick.com/imds/fda4.jpg) "Attached to CDRH Assignment #4811 was an advertisement which was promoting their [the Grables] Lintro-scan as equal to or better than mammagraphy [sic] for the early detection of breast cancer. I showed the copy of the advertisement printed in November/December, 1985, Journal of Medical Imagery and Therapy. Mr. Grable provided me with a publication of their magazine and I made a copy of the cover page, advertisement article and the back cover page (Exhibit #3). Mr. Grable stated that a copy of this advertisement was shipped with only one device. Mr. Grable stated that the advertisement is no longer being shipped with the devices. "Mr. Grable state that he provides his customers with a folder of advertising literature for his Lintro-Scans. Mr. Grable stated that the literature is provided sometimes before and after a device has been shipped. Mr. Grable stated that the literature is also passed out at trade shows by his salesmen and by himself. There are four different pieces of literature in the folder. Some make claims that the Lintro-Scan is an effective way for early detection of breast cancer through non-invasive transillumination." (Bold letter emphasis mine.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next